THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- South Star Battery Metals Corp. (“South Star” or the “Company”) (TSXV: STS) (OTCQB: STSBF), is pleased to announce the successful production and shipment of the first container of natural flake graphite concentrates, as well provide an operational update for the Santa Cruz Graphite Mine in Bahia, Brazil. The maiden shipment comprised of 20 b ...

The Kroger Co. (NYSE: KR ) has been on a tear and is trading near an all-time high. Its share price has climbed nearly 36% over the past year and is up almost 20% in 2025 alone. At first glance, thisAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in KR over the next 72 hours. I wrote this article myself, and it ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. QUÉBEC CITY, May 07, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (TSX-V: RBX) announces that, in reference to its prospectus dated April 17 2025 (Original Prospectus), it has lodged a replacement prospectus (Replacement Prospectus) with the Australian Securities and Investment Commission (ASIC) for an Initial Public Offer (IPO) to raise A$120 million (before costs) ...

Core Insights - The company reported a decrease in U.S. GAAP net sales of approximately 2% for the first quarter of 2025 compared to the same period in 2024, with net sales totaling $3,515 million [5][6][14] - Adjusted earnings per diluted share increased by approximately 8% to $1.11 in Q1 2025, up from $1.03 in Q1 2024, despite a decline in net earnings per diluted share from $0.93 to $0.72 [4][6] - The company has provided full-year 2025 guidance, expecting net sales between $13.6 billion and $14.2 billion, reflecting slight growth from 2024 sales of approximately $14.1 billion [7][8] Financial Performance - U.S. GAAP net earnings for Q1 2025 were $157 million, down from $213 million in Q1 2024, while adjusted net earnings were $1.11 per diluted share, an increase from $1.03 [6][14] - The company achieved an adjusted operating margin of 10.0% in Q1 2025, compared to a U.S. GAAP operating margin of 6.7%, reflecting a 60 basis point improvement year-over-year [5][6] - The company reported net cash provided by operating activities of $82 million for Q1 2025, a significant improvement from a net cash used of $(118) million in Q1 2024 [17] Business Developments - The company secured multiple new business awards, including a high-volume hybrid eMotor award and a high-voltage coolant heater award, which are expected to support long-term profitable growth [2][5] - The company plans to exit its Charging business, which is anticipated to eliminate approximately $30 million in annualized adjusted operating losses [5][6] - The company is consolidating its North American Battery Systems business, aiming for annual cost savings of approximately $20 million by 2026 [5] Market Outlook - The company expects its weighted light and commercial vehicle markets to decline by 4% to 2% in 2025, a revision from the previous estimate of down 3% to down 1% [7][8] - The sales guidance implies a year-over-year change in organic sales of down 2% to up 2%, with an estimated outgrowth above market production of approximately 200 to 400 basis points [7][8] - The company anticipates operating margins in the range of 8.1% to 8.6% for 2025, with adjusted operating margins expected to be between 9.6% and 10.2% [8]

Core Viewpoint - Coterra Energy Inc. reported strong operational performance in Q1 2025, with adjusted earnings per share of 78 cents, surpassing estimates and the previous year's performance, despite missing revenue expectations due to weaker oil prices. Financial Performance - Adjusted earnings per share for Q1 2025 were 78 cents, beating the Zacks Consensus Estimate of 76 cents and up from 50 cents in the year-ago quarter [1] - Operating revenues were $1.9 billion, missing estimates by $37 million but significantly higher than $1.4 billion from the previous year [2] - Cash flow from operations increased by 33.6% to $1.1 billion, with free cash flow for the quarter amounting to $663 million [13] Production and Pricing - Average daily production rose 8.8% to 746.8 thousand barrels of oil equivalent (Mboe), exceeding the Zacks Consensus Estimate of 740 Mboe [7] - Oil production increased 37.8% to 141.2 thousand barrels (MBbl) per day, although it missed the estimate of 144 MBbl [8] - Average realized crude oil price was $69.73 per barrel, down 7.2% from $75.16 a year ago, slightly missing the estimate of $70 [9] Shareholder Returns - The board declared a quarterly dividend of 22 cents per share, representing a 3.4% annualized yield [3] - Total shareholder returns for the quarter reached $192 million, including $168 million in dividends and $24 million in share repurchases [5] - The company repurchased 0.9 million shares for $24 million at an average price of $27.54 per share [4] Debt Management - Coterra is focused on debt reduction, repaying approximately $250 million during the quarter and planning to retire $750 million in term loans maturing in 2027 and 2028 [6][5] - As of March 31, 2025, the company had $186 million in cash and cash equivalents and a total liquidity of about $2.2 billion [14] Guidance - For Q2 2025, Coterra expects total equivalent production between 710 to 760 thousand barrels of oil equivalent per day [16] - The company has lowered its full-year 2025 capital expenditures range to $2-$2.3 billion [15] - Estimated discretionary cash flow for 2025 is approximately $4.3 billion, with free cash flow around $2.1 billion based on commodity price assumptions [17]

Core Viewpoint - Qifu Technology, a leading AI-empowered Credit-Tech platform in China, is set to report its unaudited financial results for Q1 2025 on May 19, 2025, after U.S. markets close [1]. Financial Results Announcement - The unaudited financial results for the first quarter ended March 31, 2025, will be reported after U.S. markets close on May 19, 2025 [1]. - An earnings conference call will be hosted by the management team at 8:30 PM U.S. Eastern Time on May 19, 2025 [2]. Conference Call Details - Participants must pre-register online to join the conference call, with a registration link provided [3]. - A live and archived webcast of the conference call will be available on the Investor Relations section of the Company's website [4]. Company Overview - Qifu Technology is recognized as a leading AI-empowered Credit-Tech platform in China, utilizing machine learning models and data analytics to offer a comprehensive suite of technology services [5]. - The Company aims to enhance accessibility and personalization of credit services for consumers and SMEs through its Credit-Tech services [5].

Core Viewpoint - Newcore Gold Ltd. has reported significant drill results from its ongoing 35,000-metre drill program at the Enchi Gold Project in Ghana, particularly at the Boin Gold Deposit, indicating multiple wide zones of gold mineralization and higher-grade intervals, which suggest strong potential for resource growth [1][4][12]. Drilling Program Overview - The drill program aims to enhance resource growth and convert Inferred Resources to Indicated, with the first phase focused on resource conversion ahead of a Pre-Feasibility Study [2][13]. - A total of 14 Reverse Circulation (RC) holes totaling 2,055 metres have been reported, with all holes intersecting gold mineralization [4][9]. Significant Drill Results - Notable intersections include: - Hole KBRC352: 2.25 g/t Au over 56.0 m from 96 m, with a higher-grade interval of 3.83 g/t Au over 15.0 m from 122 m [5][6]. - Hole KBRC344: 1.16 g/t Au over 72.0 m from 104 m, including 3.06 g/t Au over 10.0 m from 114 m [5][11]. - Additional results from other holes include KBRC355 with 2.13 g/t Au over 29.0 m and KBRC353 with 2.15 g/t Au over 24.0 m [6][10]. Resource Estimate and Potential - The Boin Gold Deposit has an Indicated Mineral Resource of 13.0 million tonnes grading 0.62 g/t Au and an Inferred Mineral Resource of 15.9 million tonnes grading 0.68 g/t Au [15]. - Approximately 40% of the gold-in-soil anomaly at Boin remains untested, indicating further exploration potential [15]. Future Exploration and Development - The ongoing work program includes metallurgical testwork, trenching, hydrogeological testing, and soil sampling to define early-stage targets for future drilling [14][19]. - The drill program is a critical step in advancing the Enchi Gold Project, with the potential for significant resource growth across the district-scale property [13][22].

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading [1]. Group 1 - The website provides general news, publications, and personal analysis intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to perform their own research and consider their financial situation before making decisions [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to understand how these instruments work and the associated risks before investing [1].

Core Insights - The company reported a total revenue of $143 million for the quarter ended March 31, 2025, reflecting a 5% increase year-over-year, driven by growth in Sample Management Solutions and Multiomics [2][7] - The diluted EPS from continuing operations was $(0.40), compared to $(0.29) in the same quarter of the previous year, indicating a significant loss [2][24] - The company has a strong cash position with total cash, cash equivalents, and marketable securities amounting to $540 million as of March 31, 2025 [14] Financial Performance - Revenue from continuing operations was $143 million, down 3% from the previous quarter but up 5% year-over-year [2][7] - Organic revenue growth was 6% year-over-year, with Sample Management Solutions revenue at $80 million, up 8% year-over-year [2][7] - Adjusted EBITDA for continuing operations was $14 million, with an adjusted EBITDA margin of 10.0%, an improvement of 400 basis points year-over-year [2][7] Management Commentary - The CEO highlighted the company's strong performance amidst a challenging macroeconomic environment, emphasizing the resilience of the portfolio and the commitment of the teams [3] - The management expressed confidence in the company's positioning and disciplined operations while navigating uncertainties [3] Cash Flow and Guidance - Operating cash flow for the quarter was $14 million, with capital expenditures of $7 million, resulting in free cash flow of $7 million [14] - The company reiterated its revenue guidance for fiscal year 2025, expecting total organic revenue growth in the range of 3% to 5% compared to fiscal 2024 [14]

Company Overview - BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) is a leading developer of adult stem cell therapeutics aimed at treating neurodegenerative diseases [3][4] - The company's proprietary NurOwn® platform utilizes autologous mesenchymal stem cells (MSCs) to create neurotrophic factor-secreting cells (MSC-NTF cells) [3][4] Upcoming Conference Call - A conference call is scheduled for May 15, 2025, at 8:30 a.m. Eastern Time to discuss the financial results for Q1 2025 and provide a corporate update [1][2] - The call will feature BrainStorm's President & CEO Chaim Lebovits, along with Dr. Bob Dagher, Chief Medical Officer, and Alla Patlis, Interim CFO [2] Clinical Development - NurOwn® is the lead investigational therapy for amyotrophic lateral sclerosis (ALS) and has received Orphan Drug designation from both the FDA and EMA [4] - A Phase 3 trial for ALS has been completed, and a confirmatory Phase 3b trial is set to launch under a Special Protocol Assessment (SPA) agreement with the FDA [4] - The clinical program has provided insights into ALS disease biology, including pharmacogenomic responses and biomarker data [4] Additional Research and Development - BrainStorm has completed a Phase 2 open-label multicenter trial of MSC-NTF cells in progressive multiple sclerosis (MS), supported by a grant from the National MS Society [4] - The company is also advancing an allogeneic exosome-based platform for delivering therapeutic proteins and nucleic acids, with a foundational patent recently allowed by the U.S. Patent and Trademark Office [4]